Search results
Found 10537 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
David Jackson
Group Leaders MRC TIDU
B.A. (Natural Sciences), Ph.D. (Biochemistry) David Jackson - Professor of Human Immunology
Anindita Roy
Group Leaders MRC MHU
MRCPCH FRCPath PhD Anindita Roy - Professor of Paediatric Haematology
Alain Townsend
Group Leaders MRC TIDU
FRS FRCP Alain Townsend - Emeritus Professor of Molecular Immunology
Bethan Psaila
Group Leaders MRC MHU
MA; MBBS; MRCP; FRCPath; PhD Bethan Psaila - Associate Professor of Haematology
Ahmed Ahmed
Group Leaders
MBBCH, MSc, MD, MRCOG, PhD Ahmed Ahmed - Professor of Gynaecological Oncology
Jill Brown
MRC MHU Researchers
BSc (Hons), Postgraduate Certificate in Clinical Cytogenetics Jill Brown - Research Assistant
Noemi Roy
MRC MHU Researchers
MBChB; BSc; DPhil; MRCP; FRCPath Noemi Roy - Associate Professor of Molecular Haematology